Richard William Scalzo net worth and biography

Richard Scalzo Biography and Net Worth

Insider of Dyne Therapeutics

Richard Scalzo is the VP of Accounting & Admin. and Treasurer at Dyne Therapeutics.

What is Richard William Scalzo's net worth?: The estimated net worth of Richard William Scalzo is at least $916,251.70 as of March 11th, 2025. Mr. Scalzo owns 122,330 shares of Dyne Therapeutics stock worth more than $916,252 as of April 7th. This net worth evaluation does not reflect any other assets that Mr. Scalzo may own. Learn More about Richard William Scalzo's net worth.
How old is Richard William Scalzo?: Mr. Scalzo is currently 38 years old. There are 7 older executives and no younger executives at Dyne Therapeutics. The oldest executive at Dyne Therapeutics is Dr. Oxana Beskrovnaya Ph.D., Chief Scientific Officer, who is 63 years old. Learn More on Richard William Scalzo's age.
How do I contact Richard William Scalzo?: The corporate mailing address for Mr. Scalzo and other Dyne Therapeutics executives is 1560 Trapelo Road, Waltham, MA 02451, United States. Dyne Therapeutics can also be reached via phone at 781-786-8230 and via email at ir@dyne-tx.com. Learn More on Richard William Scalzo's contact information.
Has Richard William Scalzo been buying or selling shares of Dyne Therapeutics?: Richard William Scalzo has not been actively trading shares of Dyne Therapeutics during the last quarter. Most recently, Richard William Scalzo sold 1,343 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $11.38, for a transaction totalling $15,283.34. Following the completion of the sale, the senior vice president now directly owns 122,330 shares of the company's stock, valued at $1,392,115.40. Learn More on Richard William Scalzo's trading history.
Who are Dyne Therapeutics' active insiders?: Dyne Therapeutics' insider roster includes Oxana Beskrovnaya (Chief Scientific Officer), Joshua Brumm (CEO), John Cox (President & CEO), Wildon Farwell (Insider), Johanna Friedl-Naderer (Chief Commercial Officer), Susanna High (COO), Carlo Incerti (Director), Dirk Kersten (Director), and Richard Scalzo (Insider). Learn More on Dyne Therapeutics' active insiders.
Are insiders buying or selling shares of Dyne Therapeutics?: During the last year, Dyne Therapeutics insiders bought shares 1 times. They purchased a total of 32,000 shares worth more than $1,057,280.00. During the last year, insiders at the sold shares 25 times. They sold a total of 388,416 shares worth more than $12,878,411.80. The most recent insider tranaction occured on March, 13th when insider Johanna Friedl-Naderer sold 143 shares worth more than $1,733.16. Insiders at Dyne Therapeutics own 20.8% of the company. Learn More about insider trades at Dyne Therapeutics.
Information on this page was last updated on 3/13/2025.

Richard William Scalzo Insider Trading History at Dyne Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2025	Sell	1,343	$11.38	$15,283.34	122,330
12/11/2024	Sell	1,455	$28.12	$40,914.60	127,078
9/18/2024	Sell	1,390	$34.55	$48,024.50	98,568
6/10/2024	Sell	1,590	$30.23	$48,065.70	115,105
5/16/2024	Sell	2,588	$28.27	$73,162.76	116,695
3/11/2024	Sell	2,672	$25.28	$67,548.16	119,283
3/7/2024	Sell	2,273	$25.85	$58,757.05	121,955
2/29/2024	Sell	3,429	$27.50	$94,297.50	124,228
1/26/2024	Sell	13,000	$24.34	$316,420.00	124,228
1/3/2024	Sell	13,000	$18.81	$244,530.00	124,228
12/14/2023	Sell	2,376	$12.02	$28,559.52	124,228
12/11/2023	Sell	1,380	$10.72	$14,793.60	126,604
12/6/2023	Sell	1,872	$12.01	$22,482.72	127,984
12/4/2023	Sell	681	$12.01	$8,178.81	129,856
9/18/2023	Sell	1,290	$9.41	$12,138.90	40,795
6/15/2023	Sell	10,000	$12.03	$120,300.00	43,482
3/14/2023	Sell	1,311	$13.33	$17,475.63	54,872
12/12/2022	Sell	312	$10.87	$3,391.44	56,183
3/11/2022	Sell	308	$8.73	$2,688.84
9/20/2021	Sell	367	$15.61	$5,728.87

See Full Table

Richard William Scalzo Buying and Selling Activity at Dyne Therapeutics

Dyne Therapeutics Company Overview

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $7.49

$7.26

$8.38

50 Day Range

MA: $12.81

$8.28

$16.76

2 Week Range

Now: $7.49

$7.27

$47.45

Volume

2,770,876 shs

Average Volume

1,430,982 shs

Market Capitalization

$847.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Richard Scalzo Biography and Net Worth

What is Richard William Scalzo's net worth?

How old is Richard William Scalzo?

How do I contact Richard William Scalzo?

Has Richard William Scalzo been buying or selling shares of Dyne Therapeutics?

Who are Dyne Therapeutics' active insiders?

Are insiders buying or selling shares of Dyne Therapeutics?